PureTech Health plc Logo

PureTech Health plc

A clinical-stage biotherapeutics company developing new medicines for devastating diseases.

PRTC | IL

Overview

Corporate Details

ISIN(s):
GB00BPVG5C82 (+2 more)
LEI:
213800LVPDNO2Z9T9I39
Country:
United States of America
Address:
6 TIDE STREET, 2210 BOSTON

Description

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-18 08:25
PureTech Appoints Robert Lyne as CEO
English 14.7 KB
2025-12-10 18:55
Results of AGM on June 16, 2025 – Update Statement
English 11.9 KB
2025-12-10 18:40
Holding(s) in Company
English 20.6 KB
2025-12-08 08:35
PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
English 23.7 KB
2025-12-05 19:10
PRTC's Gallop: Positive Initial Topline AML Data
English 26.5 KB
2025-11-18 18:40
Holding(s) in Company
English 23.7 KB
2025-11-07 19:30
Holding(s) in Company
English 23.7 KB
2025-11-03 15:10
PRTC: New LYT-200 AML Data + Update at ASH
English 24.0 KB
2025-10-22 08:00
PRTC: New IPF Data Show Benefit in Older Patients
English 23.8 KB
2025-10-17 18:30
Holding(s) in Company
English 25.4 KB
2025-10-14 08:00
Holding(s) in Company
English 25.3 KB
2025-10-10 18:59
Holding(s) in Company
English 25.4 KB
2025-10-09 19:10
Holding(s) in Company
English 25.4 KB
2025-10-01 08:00
Holding(s) in Company
English 52.0 KB
2025-09-29 08:00
PRTC: New IPF Data Show Switch Patients Stabilized
English 28.1 KB

Automate Your Workflow. Get a real-time feed of all PureTech Health plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PureTech Health plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PureTech Health plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CELADON PHARMACEUTICALS PLC Logo
Researches, cultivates, and manufactures cannabinoid-based medicines for chronic pain.
United Kingdom
CEL
Celemics, Inc. Logo
Develops NGS target enrichment solutions for research and clinical applications.
South Korea
331920
Develops radiopharmaceuticals and radioligand therapies for oncology.
South Korea
308430
CELL BIOTECH CO ., LTD Logo
Develops and manufactures probiotic solutions using patented dual-coating technology.
South Korea
049960
Celldex Therapeutics, Inc. Logo
Develops antibody-based immunotherapies for severe inflammatory and allergic diseases.
United States of America
CLDX
Cellectar Biosciences, Inc. Logo
Clinical-stage biopharma developing targeted cancer treatments via a PDC platform.
United States of America
CLRB
Cellectis Logo
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunotherapies for cancer.
France
ALCLS
Cellid Co., Ltd. Logo
Develops immunotherapeutic vaccines for cancer and infectious diseases.
South Korea
299660
Cellromax Science Co., Ltd. Logo
Researches and develops health foods, derma-cosmetics, and OTC pharmaceuticals.
South Korea
471820
CellSeed Inc. Logo
Develops and commercializes cell sheet engineering for regenerative medicine.
Japan
7776

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.